As of August 21, 2026, the global animal health sector has witnessed significant intellectual property activity, with patents granted across veterinary vaccines, biologics, feed additives, diagnostics, pet food and digital health technologies.
This report synthesizes verified patent grants from major jurisdictions (US, EU, India, WIPO/PCT) to companies, startups, and research institutes year-to-date. However, this report is not an exhaustive report and may still have NOT been able to capture all the Patents granted in AH Sector YTD 2026.
Executive Summary
The first eight months of 2026 have seen at least 25+ confirmed patent grants in the animal health sector, with notable concentration in:
-
Veterinary vaccines (feline, poultry, swine, cattle)
-
Engineered probiotics and biologics
-
Feed additives and nutritional innovations
-
Parasiticides and antimicrobial technologies
-
Digital livestock monitoring systems
Major patent holders include BiomEdit, Zoetis, Boehringer Ingelheim, Intervet (MSD), Merck Animal Health, Phytobiotics, ZymIQ Technology, and several Indian entities including ICAR institutes and startups like V V Canine Foods Pharma.
Patent Grants by Category
1. Veterinary Vaccines & Immunologicals
Key Insight: The first RNA-based veterinary vaccine in Europe (Nobivac NXT series) marks a regulatory and technological milestone, extending mRNA platform advantages from human to animal health.eanpages+1
2. Biologics, Probiotics & Antimicrobial Alternatives
BiomEdit’s patents protect its lead product BE-101, a non-antibiotic therapy using engineered Lactobacillus to deliver antibodies directly in the host gut—positioned for USDA CVB conditional licensure.linkedin+1
3. Feed Additives & Nutritional Innovations
India’s V V Canine Foods Pharma became one of the few Indian startups to secure a process patent for vegan animal nutrition, targeting both livestock and pet segments with plant-based formulations.linkedin
4. Parasiticides, Antimicrobials & Therapeutics
While EUAs are not patents, they reflect rapid regulatory deployment of existing patented compounds (e.g., afoxolaner, sarolaner) for emergency parasite control.prnewswire+2
5. Digital Health, Monitoring & Diagnostics
These patents reflect the convergence of IoT, AI, and veterinary medicine, enabling real-time disease detection and welfare monitoring.
6. Research Institute & Public Sector Patents
ICAR’s licensing of Lumpi-ProVac Ind to Brilliant Bio Pharma exemplifies India’s push for indigenous vaccine self-reliance following the 2022–2023 LSD outbreak.
Notable Startups & SMEs
Key Technology Trends
-
RNA/mRNA Vaccines for Animals: EMA’s endorsement of Nobivac NXT series signals regulatory readiness for mRNA platforms beyond human medicine
-
Non-Antibiotic Disease Control: BiomEdit’s engineered probiotics and ZymIQ’s enzyme technology reflect the sector’s shift away from traditional antibiotics amid antimicrobial resistance concerns
-
Sustainability & Methane Reduction: Nestlé’s methane-inhibiting feed additive and phytogenic innovations (Phytobiotics) align with climate-focused livestock production
-
Precision Livestock Farming: AI-driven monitoring patents (IT Tech Co., FeverTags) enable real-time health tracking, reducing mortality and improving welfare
-
Indigenous Vaccine Development: India’s ICAR-led LSD vaccine and Oxford-SII Nipah collaboration highlight geopolitical diversification of vaccine supply chains
Patent Expiries & Generic Opportunities
-
Boehringer Ingelheim’s NexGard PLUS patents (US 8,623,875; US 9,095,138; US 8,231,888) expire December 28, 2026, opening opportunities for generic afoxolaner/moxidectin/pyrantel combinations
-
Viyash Scientific (Indian animal health company) is positioned to benefit from 17 companion animal drug patent expiries over the next four years
Data Limitations & Notes
-
This report captures publicly announced or published patent grants; many national-phase grants (especially in China, Brazil, Japan) may not have been captured in this report
-
Emergency Use Authorizations (EUAs) are regulatory approvals, not patents, but are included where they reference patented compounds
